| SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ... Nature 596 (7870), 109-113, 2021 | 795 | 2021 |
| SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans JS Turner, W Kim, E Kalaidina, CW Goss, AM Rauseo, AJ Schmitz, ... Nature 595 (7867), 421-425, 2021 | 607 | 2021 |
| Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ... Science immunology 6 (59), eabh2259, 2021 | 209 | 2021 |
| Hope on the horizon: novel fungal treatments in development AM Rauseo, A Coler-Reilly, L Larson, A Spec Open Forum Infectious Diseases 7 (2), ofaa016, 2020 | 199 | 2020 |
| Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19 D Scozzi, M Cano, L Ma, D Zhou, JH Zhu, JA O’Halloran, C Goss, ... JCI insight 6 (4), 2021 | 183 | 2021 |
| The geographic distribution of dimorphic mycoses in the United States for the modern era PB Mazi, JM Sahrmann, MA Olsen, A Coler-Reilly, AM Rauseo, M Pullen, ... Clinical Infectious Diseases 76 (7), 1295-1301, 2023 | 77 | 2023 |
| Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial EK JA O'Halloran, ER Ko, KJ Anstrom JAMA 324 (11), 1048-57, 2023 | 61* | 2023 |
| Blastomycosis PB Mazi, AM Rauseo, A Spec Infectious Disease Clinics 35 (2), 515-530, 2021 | 53 | 2021 |
| Attributable Mortality of Candida Bloodstream Infections in the Modern Era: A Propensity Score Analysis PB Mazi, MA Olsen, D Stwalley, AM Rauseo, C Ayres, WG Powderly, ... Clinical Infectious Diseases 75 (6), 1031-1036, 2022 | 43 | 2022 |
| Voriconazole versus itraconazole for the initial and step-down treatment of histoplasmosis: a retrospective cohort MJ Hendrix, L Larson, AM Rauseo, S Rutjanawech, AD Franklin, ... Clinical Infectious Diseases 73 (11), e3727-e3732, 2021 | 33 | 2021 |
| A comparison of presentations and outcomes of histoplasmosis across patients with varying immune status AD Franklin, L Larson, AM Rauseo, S Rutjanawech, MJ Hendrix, ... Medical Mycology 59 (6), 624-633, 2021 | 33 | 2021 |
| Asthma in patients with suspected and diagnosed coronavirus disease 2019 L Cao, S Lee, JG Krings, AM Rauseo, D Reynolds, R Presti, C Goss, ... Annals of Allergy, Asthma & Immunology 126 (5), 535-541. e2, 2021 | 23* | 2021 |
| Performance of the lateral flow assay and the latex agglutination serum cryptococcal antigen test in cryptococcal disease in patients with and without HIV MA Hevey, IA George, AM Rauseo, L Larson, W Powderly, A Spec Journal of clinical microbiology 58 (11), 10.1128/jcm. 01563-20, 2020 | 22 | 2020 |
| Bioavailability of single-dose SUBA-itraconazole compared to conventional itraconazole under fasted and fed conditions AM Rauseo, P Mazi, P Lewis, B Burnett, S Mudge, A Spec Antimicrobial agents and chemotherapy 65 (8), 10.1128/aac. 00134-21, 2021 | 18 | 2021 |
| Management of histoplasmosis by infectious disease physicians PB Mazi, SR Arnold, JW Baddley, NC Bahr, SE Beekmann, TP McCarty, ... Open forum infectious diseases 9 (7), ofac313, 2022 | 17 | 2022 |
| The salivary and nasopharyngeal microbiomes are associated with SARS‐CoV‐2 infection and disease severity JG Kim, A Zhang, AM Rauseo, CW Goss, PA Mudd, JA O'Halloran, ... Journal of medical virology 95 (2), e28445, 2023 | 15 | 2023 |
| Long-Term Mortality after Histoplasma Infection in People with HIV J Cherabie, P Mazi, AM Rauseo, C Ayres, L Larson, S Rutjanawech, ... Journal of Fungi 7 (5), 369, 2021 | 14 | 2021 |
| Estimating the effects of race and social vulnerability on hospital admission and mortality from COVID-19 JM Landman, K Steger-May, KE Joynt Maddox, G Hammond, A Gupta, ... JAMIA open 4 (4), ooab111, 2021 | 13 | 2021 |
| Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis L Di Stefano, EL Ogburn, M Ram, DO Scharfstein, T Li, P Khanal, ... PloS one 17 (9), e0273526, 2022 | 12 | 2022 |
| A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization AM Rauseo, T Hink, KA Reske, SM Seiler, KM Bommarito, VJ Fraser, ... Infection Control & Hospital Epidemiology 43 (2), 167-173, 2022 | 11 | 2022 |
